Curcumin is the polyphenol that is one of the most potent natural inhibitors of the inflammatory signalling — it is the primary active component of the turmeric (Curcuma longa) and it is one of the most extensively studied and most evidence-based anti-inflammatory compounds in the botanical medicine tradition. Curcumin inhibits the NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) pathway through multiple and complementary mechanisms — it inhibits the IκB kinase (IKK) activity, it prevents the IκB degradation, it blocks the NF-κB nuclear translocation, it inhibits the NF-κB DNA binding activity, and it suppresses the expression of the NF-κB target genes (including the COX-2, the iNOS, the TNF-alpha, the IL-1 beta, the IL-6, and the IL-8). The NF-κB pathway is one of the most important and most evolutionarily conserved inflammatory signalling pathways in the human body — it is activated by the cytokines, the bacterial toxins, the reactive oxygen species, the UV radiation, and the metabolic stress, and it regulates the expression of the genes that are responsible for the inflammation, the cell proliferation, the apoptosis inhibition, and the angiogenesis. The chronic activation of the NF-κB pathway is one of the most important and most common mechanisms of the chronic inflammation, the metabolic syndrome, the neurodegeneration, and the cancer progression — and it is therefore one of the most important and most widely targeted pathways in the drug development and in the nutritional intervention. Curcumin is unique among the NF-κB inhibitors because it has multiple and complementary mechanisms of action (simultaneous inhibition of the IKK, the IκB, the nuclear translocation, the DNA binding, and the gene expression), and because it has a very good safety profile and a long history of use in the traditional medicine systems — making it one of the most effective and most accessible anti-inflammatory compounds available. Without adequate curcumin and NF-κB inhibition, the inflammation is chronic, the metabolic dysfunction develops, and the cancer progresses — the hallmark of the curcumin deficiency and of the chronic inflammatory states that are associated with the metabolic syndrome, the rheumatoid arthritis, the Alzheimer’s disease, and the cancer.
Curcumin and the Multi-Target Anti-Inflammatory Effect
Curcumin supports the anti-inflammatory effect primarily through its simultaneous inhibition of multiple steps in the NF-κB pathway — it is a potent inhibitor of the IKK (IκB kinase), which is the enzyme that phosphorylates the IκB and triggers its degradation; it stabilises the IκB by preventing its phosphorylation and degradation; it blocks the NF-κB nuclear translocation by preventing the p65/p50 complex from entering the nucleus; it inhibits the NF-κB DNA binding activity by directly binding to the NF-κB protein; and it suppresses the expression of the NF-κB target genes by interfering with the transcriptional coactivators (CBP, p300) that are required for the NF-κB-mediated gene transcription. This multi-target mechanism of action (simultaneously inhibiting the IKK, stabilising the IκB, blocking the nuclear translocation, inhibiting the DNA binding, and suppressing the gene expression) makes curcumin one of the most comprehensive and most potent natural inhibitors of the NF-κB pathway known — and it explains why the curcumin has such broad and potent anti-inflammatory, anti-cancer, and neuroprotective effects in the experimental models and in the human studies.
The clinical importance of the curcumin for the inflammation and for the metabolic syndrome is underscored by the observation that the curcumin supplementation reduces the markers of the inflammation and improves the metabolic parameters in people with the metabolic syndrome, the rheumatoid arthritis, and the depression. A study in 60 patients with the metabolic syndrome found that the curcumin supplementation at 500mg twice daily for 12 weeks significantly reduced the CRP (by 30-40%), reduced the TNF-alpha (by 20-30%), reduced the fasting blood glucose (by 10-15%), and improved the lipid profile (by reducing the triglycerides and the LDL cholesterol) — demonstrating the potent and clinically meaningful anti-inflammatory and metabolic-protective effect of the curcumin in humans with the metabolic syndrome.
Practical Application
For general curcumin supplementation for the anti-inflammatory effect and for the NF-κB pathway inhibition, the evidence-based approach is to supplement with 500-1000mg of curcumin daily (as the standardised turmeric extract that is standardised to contain 95% curcuminoids, taken with the meals and with the black pepper extract (piperine) to enhance the absorption). The curcumin should be taken with the black pepper extract (piperine at 5-10mg, which enhances the curcumin absorption by 2000-3000% through the inhibition of the glucuronidation) and with the meals that contain some fat (to enhance the absorption of the fat-soluble curcumin). The curcumin is generally well-tolerated with no significant adverse effects at the doses that are used for the anti-inflammatory support (up to 2000mg daily), and it does not have any known drug interactions or contraindications — though people who are taking the blood-thinning medications (warfarin, clopidogrel, aspirin) should use the curcumin with caution and under the supervision of a qualified healthcare practitioner, because the curcumin has antiplatelet effects and may potentiate the effects of these medications. For comprehensive anti-inflammatory and NF-κB inhibition support, curcumin pairs well with the ginger (which is another potent anti-inflammatory polyphenol that works synergistically with the curcumin for the NF-κB inhibition and for the reduction of the inflammation — the combination of the curcumin and the ginger is one of the most effective and most evidence-based combinations for the anti-inflammatory effect and for the prevention of the chronic inflammatory diseases), with the omega-3 fatty acids (which are the precursors of the resolvins and the protectins, and which work synergistically with the curcumin for the resolution of the inflammation — the combination of the curcumin and the omega-3 fatty acids is one of the most effective approaches for the anti-inflammatory effect and for the prevention of the chronic inflammatory diseases), with the resveratrol (which is a potent sirtuin activator and NF-κB inhibitor that works synergistically with the curcumin for the anti-inflammatory effect and for the cellular protection — the combination of the curcumin and the resveratrol is one of the most effective combinations for the prevention of the neurodegenerative diseases and for the anti-ageing), and with the vitamin D (which is a regulator of the immune function and which works synergistically with the curcumin for the modulation of the immune response and for the prevention of the autoimmune diseases — the combination of the curcumin and the vitamin D is one of the most effective combinations for the prevention and the treatment of the autoimmune diseases).
Leave a Reply